Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Insmed - 25 Year Stock Price History | INSM

Historical daily share price chart and data for Insmed since 2000 adjusted for splits and dividends. The latest closing stock price for Insmed as of January 17, 2025 is 72.51.
  • The all-time high Insmed stock closing price was 195.00 on August 30, 2000.
  • The Insmed 52-week high stock price is 80.53, which is 11.1% above the current share price.
  • The Insmed 52-week low stock price is 21.92, which is 69.8% below the current share price.
  • The average Insmed stock price for the last 52 weeks is 55.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Insmed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 68.7445 69.9500 72.7500 65.2500 72.5100 5.03%
2024 53.5032 29.9400 79.0100 22.0000 69.0400 122.78%
2023 21.8217 19.1800 31.7400 16.2600 30.9900 55.11%
2022 21.8800 28.1300 28.2100 16.9800 19.9800 -26.65%
2021 30.5951 33.4200 44.3000 22.4600 27.2400 -18.17%
2020 28.2231 23.6600 40.5400 13.6300 33.2900 39.41%
2019 23.3077 13.9700 32.1900 13.9100 23.8800 82.01%
2018 22.6387 32.4600 32.9900 11.6000 13.1200 -57.92%
2017 20.2914 13.0800 31.7800 11.6100 31.1800 135.68%
2016 12.7351 17.2400 17.2400 9.0500 13.2300 -27.11%
2015 20.7534 15.9600 27.5400 14.1600 18.1500 17.32%
2014 15.7364 17.1400 21.5400 11.6500 15.4700 -9.00%
2013 11.2478 6.9600 17.3300 5.7200 17.0000 154.11%
2012 4.3827 3.1500 8.0000 2.7000 6.6900 119.34%
2011 6.4065 6.4000 13.1500 2.6400 3.0500 -51.65%
2010 8.1390 7.7000 12.5000 5.7000 6.3080 -18.08%
2009 9.7689 4.9000 24.7000 4.1500 7.7000 64.71%
2008 6.0865 8.3000 9.1000 3.4990 4.6750 -43.33%
2007 8.8034 9.0000 15.6000 5.7700 8.2500 -6.25%
2006 16.1210 21.3000 31.2000 8.5000 8.8000 -55.33%
2005 12.6992 23.0000 23.0000 8.2000 19.7000 -10.41%
2004 23.1546 30.3000 40.9000 10.1000 21.9900 -25.96%
2003 20.0198 4.8000 34.2000 4.1000 29.7000 561.47%
2002 17.7447 39.4000 39.4000 3.5000 4.4900 -88.25%
2001 45.0069 37.5000 89.9000 24.7000 38.2000 10.12%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.972B $0.305B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $146.268B 14.16
Gilead Sciences (GILD) United States $114.457B 20.73
Bristol Myers Squibb (BMY) United States $114.166B 48.11
Vertex Pharmaceuticals (VRTX) United States $108.677B 0.00
CSL (CSLLY) Australia $83.439B 0.00
Regeneron Pharmaceuticals (REGN) United States $74.899B 17.05
GSK (GSK) United Kingdom $69.286B 8.02
Argenex SE (ARGX) Netherlands $38.667B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.764B 0.00
BioNTech SE (BNTX) Germany $26.834B 0.00
Illumina (ILMN) United States $21.676B 79.00
BeiGene (ONC) Cayman Islands $20.529B 0.00
Biogen (BIIB) United States $20.481B 8.80
Incyte (INCY) United States $13.857B 0.00
Genmab (GMAB) Denmark $13.765B 20.19
Genmab (GNMSF) Denmark $13.706B 16.44
Intra-Cellular Therapies (ITCI) United States $13.379B 0.00
Moderna (MRNA) United States $13.107B 0.00
Bio-Techne Corp (TECH) United States $12.049B 46.52
BioMarin Pharmaceutical (BMRN) United States $11.727B 27.23
Sarepta Therapeutics (SRPT) United States $11.271B 101.72
Vaxcyte (PCVX) United States $10.632B 0.00
QIAGEN (QGEN) Netherlands $10.497B 21.60
Exelixis (EXEL) United States $10.338B 23.51
Swedish Orphan Biovitrum (BIOVF) Sweden $10.075B 41.62
Exact Sciences (EXAS) United States $9.576B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.547B 32.44
Repligen (RGEN) United States $8.993B 117.16
Roivant Sciences (ROIV) United Kingdom $8.117B 0.00
Ascendis Pharma (ASND) Denmark $7.776B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.326B 7.17
Zealand Pharma (ZLDPF) Denmark $7.065B 0.00
Blueprint Medicines (BPMC) United States $6.991B 0.00
Halozyme Therapeutics (HALO) United States $6.972B 15.75
Revolution Medicines (RVMD) United States $6.778B 0.00
Legend Biotech (LEGN) United States $5.965B 0.00
Telix Pharmaceuticals (TLX) Australia $5.617B 0.00
Cytokinetics (CYTK) United States $5.398B 0.00
Nuvalent (NUVL) United States $5.389B 0.00
Alkermes (ALKS) Ireland $4.768B 16.02
TG Therapeutics (TGTX) United States $4.600B 0.00
Guardant Health (GH) United States $4.530B 0.00
Axsome Therapeutics (AXSM) United States $4.455B 0.00
Krystal Biotech (KRYS) United States $4.268B 70.66
Verona Pharma American Depositary Share (VRNA) United Kingdom $4.215B 0.00
Scholar Rock Holding (SRRK) United States $4.038B 0.00
Alvotech (ALVO) Luxembourg $4.001B 0.00
Biohaven (BHVN) United States $3.801B 0.00
ADMA Biologics Inc (ADMA) United States $3.787B 40.05
Apellis Pharmaceuticals (APLS) United States $3.724B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.694B 0.00
Viking Therapeutics (VKTX) United States $3.638B 0.00
Arcellx (ACLX) United States $3.595B 0.00
Immunovant (IMVT) United States $3.502B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.459B 0.00
Avidity Biosciences (RNA) United States $3.450B 0.00
PTC Therapeutics (PTCT) United States $3.381B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.352B 0.00
Denali Therapeutics (DNLI) United States $3.156B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.937B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.924B 22.53
Vericel (VCEL) United States $2.916B 984.50
Zai Lab (ZLAB) China $2.851B 0.00
NovoCure (NVCR) Jersey $2.832B 0.00
Twist Bioscience (TWST) United States $2.823B 0.00
Amicus Therapeutics (FOLD) United States $2.812B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.800B 0.00
Merus (MRUS) Netherlands $2.701B 0.00
Kymera Therapeutics (KYMR) United States $2.630B 0.00
SpringWorks Therapeutics (SWTX) United States $2.576B 0.00
Edgewise Therapeutics (EWTX) United States $2.487B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.475B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.434B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.254B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.227B 18.51
CG Oncology (CGON) United States $2.211B 0.00
Protagonist Therapeutics (PTGX) United States $2.194B 13.84
Janux Therapeutics (JANX) United States $2.137B 0.00
Bavarian Nordic (BVNRY) Denmark $2.130B 13.05
Ligand Pharmaceuticals (LGND) United States $2.114B 52.78
Vera Therapeutics (VERA) United States $2.113B 0.00
ImmunityBio (IBRX) United States $2.049B 0.00
Mesoblast (MESO) Australia $1.984B 0.00
Beam Therapeutics (BEAM) United States $1.941B 0.00
IDEAYA Biosciences (IDYA) United States $1.917B 0.00
Certara (CERT) United States $1.877B 53.00
Agios Pharmaceuticals (AGIO) United States $1.849B 0.00
NeoGenomics (NEO) United States $1.824B 0.00
Iovance Biotherapeutics (IOVA) United States $1.801B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.778B 0.00
Akero Therapeutics (AKRO) United States $1.755B 0.00
Geron (GERN) United States $1.747B 0.00
Belite Bio (BLTE) United States $1.736B 0.00
Disc Medicine (IRON) United States $1.733B 0.00
WAVE Life Sciences (WVE) Singapore $1.676B 0.00
Apogee Therapeutics (APGE) United States $1.669B 0.00
MannKind (MNKD) United States $1.657B 42.93
Dynavax Technologies (DVAX) United States $1.637B 95.77
Fortrea Holdings (FTRE) United States $1.587B 50.54
Celldex Therapeutics (CLDX) United States $1.578B 0.00
Galapagos (GLPG) Belgium $1.566B 0.00
Structure Therapeutics (GPCR) United States $1.549B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.484B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.452B 0.00
Viridian Therapeutics (VRDN) United States $1.436B 0.00
Travere Therapeutics (TVTX) United States $1.434B 0.00
Vir Biotechnology (VIR) United States $1.392B 0.00
Nurix Therapeutics (NRIX) United States $1.356B 0.00
Novavax (NVAX) United States $1.346B 0.00
MiMedx (MDXG) United States $1.340B 35.08
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.339B 0.00
Praxis Precision Medicines (PRAX) United States $1.315B 0.00
Arcus Biosciences (RCUS) United States $1.284B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.265B 0.00
Arvinas (ARVN) United States $1.240B 0.00
ANI Pharmaceuticals (ANIP) United States $1.229B 16.75
Myriad Genetics (MYGN) United States $1.128B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.116B 0.00
Liquidia Technologies (LQDA) United States $1.091B 0.00
Spyre Therapeutics (SYRE) United States $1.061B 0.00
Pacira BioSciences (PCRX) United States $1.032B 9.72
Gyre Therapeutics (GYRE) United States $1.024B 0.00
Adaptive Biotechnologies (ADPT) United States $1.005B 0.00
Intellia Therapeutics (NTLA) United States $0.968B 0.00
Pharvaris (PHVS) Netherlands $0.960B 0.00
Zymeworks (ZYME) United States $0.956B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.940B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.921B 0.00
Oculis Holding AG (OCS) Switzerland $0.921B 0.00
CureVac (CVAC) Germany $0.918B 7.45
Cogent Biosciences (COGT) United States $0.887B 0.00
AbCellera Biologics (ABCL) Canada $0.877B 0.00
Nuvation Bio (NUVB) United States $0.845B 0.00
ArriVent BioPharma (AVBP) United States $0.823B 0.00
Tyra Biosciences (TYRA) United States $0.819B 0.00
Avid Bioservices (CDMO) United States $0.793B 0.00
Anavex Life Sciences (AVXL) United States $0.781B 0.00
Septerna (SEPN) United States $0.750B 0.00
Prothena (PRTA) Ireland $0.741B 0.00
CorMedix Inc (CRMD) United States $0.738B 0.00
Sana Biotechnology (SANA) United States $0.706B 0.00
Cytek Biosciences (CTKB) United States $0.703B 0.00
Castle Biosciences (CSTL) United States $0.699B 124.70
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.696B 0.00
Replimune (REPL) United States $0.694B 0.00
UniQure (QURE) Netherlands $0.685B 0.00
Pliant Therapeutics (PLRX) United States $0.682B 0.00
Pharming Group (PHAR) Netherlands $0.679B 0.00
Oric Pharmaceuticals (ORIC) United States $0.676B 0.00
89BIO (ETNB) United States $0.670B 0.00
Bicara Therapeutics (BCAX) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Immatics (IMTX) Germany $0.639B 0.00
Immunome (IMNM) United States $0.624B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.623B 0.00
LENZ Therapeutics (LENZ) United States $0.619B 0.00
Arbutus Biopharma (ABUS) United States $0.606B 0.00
Tectonic Therapeutic (TECX) United States $0.603B 0.00
Cullinan Therapeutics (CGEM) United States $0.597B 0.00
Dianthus Therapeutics (DNTH) United States $0.592B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.591B 0.00
Upstream Bio (UPB) United States $0.590B 0.00
GRAIL (GRAL) United States $0.585B 0.00
CARGO Therapeutics (CRGX) United States $0.570B 0.00
Kura Oncology (KURA) United States $0.565B 0.00
Humacyte (HUMA) United States $0.555B 0.00
Emergent Biosolutions (EBS) United States $0.535B 0.00
Opthea (OPT) Australia $0.531B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.525B 0.00
Erasca (ERAS) United States $0.523B 0.00
MaxCyte (MXCT) United States $0.522B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.511B 0.00
Stoke Therapeutics (STOK) United States $0.496B 0.00
Cartesian Therapeutics (RNAC) United States $0.490B 0.00
MeiraGTx Holdings (MGTX) United States $0.489B 0.00
AnaptysBio (ANAB) United States $0.482B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.476B 0.00
Entrada Therapeutics (TRDA) United States $0.475B 7.98
Rapport Therapeutics (RAPP) United States $0.464B 0.00
GH Research (GHRS) Ireland $0.462B 0.00
Mineralys Therapeutics (MLYS) United States $0.460B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.455B 0.00
ChromaDex (CDXC) United States $0.454B 594.00
Annexon (ANNX) United States $0.448B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.444B 0.00
Keros Therapeutics (KROS) United States $0.440B 0.00
Sage Therapeutics (SAGE) United States $0.433B 0.00
Alpha Teknova (TKNO) United States $0.430B 0.00
Astria Therapeutics (ATXS) United States $0.423B 0.00
PureTech Health (PRTC) United States $0.419B 0.00
Kamada (KMDA) Israel $0.412B 25.57
Codexis (CDXS) United States $0.407B 0.00
Celcuity (CELC) United States $0.406B 0.00
Abivax SA (ABVX) France $0.390B 0.00
Aura Biosciences (AURA) United States $0.388B 0.00
Revance Therapeutics (RVNC) United States $0.384B 0.00
Allogene Therapeutics (ALLO) United States $0.382B 0.00
Prime Medicine (PRME) United States $0.379B 0.00
Kodiak Sciences (KOD) United States $0.377B 0.00
Terns Pharmaceuticals (TERN) United States $0.376B 0.00
Eton Pharmaceuticals (ETON) United States $0.375B 0.00
Northwest Biotherapeutics (NWBO) United States $0.374B 0.00
REGENXBIO (RGNX) United States $0.365B 0.00
Alumis (ALMS) United States $0.362B 0.00
Compass Therapeutics (CMPX) United States $0.358B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.347B 0.00
Absci (ABSI) United States $0.333B 0.00
Neumora Therapeutics (NMRA) United States $0.331B 0.00
MBX Biosciences (MBX) United States $0.331B 0.00
Zenas BioPharma (ZBIO) United States $0.328B 0.00
Precigen (PGEN) United States $0.325B 0.00
Olema Pharmaceuticals (OLMA) United States $0.324B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.322B 0.00
Contineum Therapeutics (CTNM) United States $0.321B 0.00
Chimerix (CMRX) United States $0.319B 0.00
EnGene Holdings (ENGN) Canada $0.316B 0.00
XOMA Royalty (XOMA) United States $0.315B 0.00
Tango Therapeutics (TNGX) United States $0.306B 0.00
ATyr Pharma (ATYR) United States $0.303B 0.00
ITeos Therapeutics (ITOS) United States $0.292B 0.00
Trevi Therapeutics (TRVI) United States $0.289B 0.00
Design Therapeutics (DSGN) United States $0.287B 0.00
Atea Pharmaceuticals (AVIR) United States $0.285B 0.00
Rezolute (RZLT) United States $0.282B 0.00
Prima BioMed (IMMP) Australia $0.281B 0.00
C4 Therapeutics (CCCC) United States $0.278B 0.00
Voyager Therapeutics (VYGR) United States $0.277B 7.14
Y-mAbs Therapeutics (YMAB) United States $0.276B 0.00
AC Immune (ACIU) Switzerland $0.265B 0.00
BioStem Technologies (BSEM) $0.265B 23.38
Third Harmonic Bio (THRD) United States $0.261B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.254B 0.00
Neurogene (NGNE) United States $0.247B 0.00
DiaMedica Therapeutics (DMAC) United States $0.244B 0.00
Nautilus Biotechnology (NAUT) United States $0.242B 0.00
Urogen Pharma (URGN) United States $0.241B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.240B 0.00
Lifecore Biomedical (LFCR) United States $0.240B 0.00
Foghorn Therapeutics (FHTX) United States $0.240B 0.00
Benitec Biopharma (BNTC) United States $0.239B 0.00
Verastem (VSTM) United States $0.237B 0.00
Anika Therapeutics (ANIK) United States $0.235B 0.00
Amarin (AMRN) Ireland $0.229B 0.00
Sangamo Therapeutics (SGMO) United States $0.227B 0.00
Abeona Therapeutics (ABEO) United States $0.227B 0.00
Molecular Partners AG (MOLN) Switzerland $0.224B 0.00
Semper Paratus Acquisition (TVGN) United States $0.224B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.223B 0.00
Gossamer Bio (GOSS) United States $0.218B 0.00
Candel Therapeutics (CADL) United States $0.216B 0.00
Fulcrum Therapeutics (FULC) United States $0.214B 0.00
Ocugen (OCGN) United States $0.207B 0.00
TuHURA Biosciences (HURA) United States $0.203B 0.00
Compugen (CGEN) Israel $0.201B 112.50
Orchestra BioMed Holdings (OBIO) United States $0.201B 0.00
ACELYRIN, INC (SLRN) United States $0.200B 0.00
Inhibrx Biosciences (INBX) United States $0.195B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.194B 0.00
BioAge Labs (BIOA) United States $0.184B 0.00
Adocia (ADOCY) France $0.183B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.177B 0.00
Cardiff Oncology (CRDF) United States $0.176B 0.00
Nkarta (NKTX) United States $0.174B 0.00
Monopar Therapeutics (MNPR) United States $0.174B 0.00
GENFIT S.A (GNFT) France $0.173B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.170B 0.00
Greenwich LifeSciences (GLSI) United States $0.169B 0.00
Actuate Therapeutics (ACTU) United States $0.168B 0.00
Alector (ALEC) United States $0.167B 0.00
Sutro Biopharma (STRO) United States $0.166B 0.00
ScPharmaceuticals (SCPH) United States $0.164B 0.00
Bright Minds Biosciences (DRUG) United States $0.163B 0.00
Coherus BioSciences (CHRS) United States $0.160B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.160B 0.00
Artiva Biotherapeutics (ARTV) United States $0.159B 0.00
Checkpoint Therapeutics (CKPT) United States $0.155B 0.00
Cidara Therapeutics (CDTX) United States $0.153B 0.00
Adherex Technologies (FENC) United States $0.153B 0.00
InflaRx (IFRX) Germany $0.150B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.148B 0.00
Puma Biotechnology (PBYI) United States $0.146B 6.19
Fate Therapeutics (FATE) United States $0.145B 0.00
Biomea Fusion (BMEA) United States $0.144B 0.00
Kyverna Therapeutics (KYTX) United States $0.144B 0.00
INmune Bio (INMB) United States $0.143B 0.00
Ventyx Biosciences (VTYX) United States $0.143B 0.00
Innate Pharma S.A (IPHA) France $0.142B 0.00
Akoya Biosciences (AKYA) United States $0.140B 0.00
Caribou Biosciences (CRBU) United States $0.139B 0.00
Instil Bio (TIL) United States $0.137B 0.00
Seer (SEER) United States $0.135B 0.00
Sagimet Biosciences (SGMT) United States $0.135B 0.00
2seventy Bio (TSVT) United States $0.135B 0.00
Cabaletta Bio (CABA) United States $0.134B 0.00
Climb Bio (CLYM) United States $0.131B 0.00
Seres Therapeutics (MCRB) United States $0.131B 0.00
Solid Biosciences (SLDB) United States $0.131B 0.00
TScan Therapeutics (TCRX) United States $0.128B 0.00
Alto Neuroscience (ANRO) United States $0.125B 0.00
Black Diamond Therapeutics (BDTX) United States $0.124B 0.00
Aligos Therapeutics (ALGS) United States $0.123B 0.00
XBiotech (XBIT) United States $0.116B 0.00
Zura Bio (ZURA) United States $0.116B 0.00
Inventiva S.A (IVA) France $0.113B 0.00
Renovaro (RENB) United States $0.112B 0.00
Tenaya Therapeutics (TNYA) United States $0.111B 0.00
Elutia (ELUT) United States $0.111B 0.00
Nuvectis Pharma (NVCT) United States $0.106B 0.00
TELA Bio (TELA) United States $0.106B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.106B 0.00
IGM Biosciences (IGMS) United States $0.105B 0.00
Editas Medicine (EDIT) United States $0.101B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.099B 0.00
Leap Therapeutics (LPTX) United States $0.098B 0.00
BioHarvest Sciences (BHST) Canada $0.096B 0.00
Alpha Cognition (ACOG) Canada $0.095B 0.00
HilleVax (HLVX) United States $0.095B 0.00
23andMe Holding (ME) United States $0.094B 0.00
CAMP4 Therapeutics (CAMP) United States $0.093B 0.00
DBV Technologies S.A (DBVT) France $0.092B 0.00
ALX Oncology Holdings (ALXO) United States $0.092B 0.00
Vor Biopharma (VOR) $0.091B 0.00
Citius Oncology (CTOR) United States $0.091B 0.00
Adverum Biotechnologies (ADVM) United States $0.090B 0.00
Coya Therapeutics (COYA) United States $0.090B 0.00
MediciNova (MNOV) United States $0.090B 0.00
Inozyme Pharma (INZY) United States $0.087B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.087B 0.00
I-Mab (IMAB) China $0.087B 0.00
X4 Pharmaceuticals (XFOR) United States $0.087B 0.00
Scilex Holding (SCLX) United States $0.086B 0.00
Immunic (IMUX) United States $0.086B 0.00
Genelux (GNLX) United States $0.085B 0.00
Entera Bio (ENTX) Israel $0.084B 0.00
Cue Biopharma (CUE) United States $0.083B 0.00
Jasper Therapeutics (JSPR) United States $0.083B 0.00
Cellectis S.A (CLLS) France $0.082B 0.00
Agenus (AGEN) United States $0.082B 0.00
Adagene (ADAG) China $0.081B 0.00
VistaGen Therapeutics (VTGN) United States $0.081B 0.00
Bluebird Bio (BLUE) United States $0.081B 0.00
Skye Bioscience (SKYE) United States $0.081B 0.00
Theratechnologies (THTX) Canada $0.079B 0.00
Vigil Neuroscience (VIGL) United States $0.079B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
Allakos (ALLK) United States $0.076B 0.00
Mersana Therapeutics (MRSN) United States $0.076B 0.00
Applied Therapeutics (APLT) United States $0.076B 0.00
Adlai Nortye (ANL) Cayman Islands $0.076B 0.00
Rani Therapeutics Holdings (RANI) United States $0.075B 0.00
PepGen (PEPG) United States $0.075B 0.00
Adicet Bio (ACET) United States $0.075B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
Aerovate Therapeutics (AVTE) United States $0.075B 0.00
Aadi Bioscience (AADI) United States $0.073B 0.00
Quince Therapeutics (QNCX) United States $0.073B 0.00
Ikena Oncology (IKNA) United States $0.072B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Annovis Bio (ANVS) United States $0.069B 0.00
BGM Group (BGM) China $0.069B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
Elicio Therapeutics (ELTX) United States $0.067B 0.00
BeyondSpring (BYSI) United States $0.067B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
Abpro Holdings (ABP) United States $0.067B 0.00
Invizyne Technologies (IZTC) United States $0.066B 0.00
CytomX Therapeutics (CTMX) United States $0.066B 4.94
Generation Bio (GBIO) United States $0.063B 0.00
Oncolytics Biotech (ONCY) Canada $0.063B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.063B 0.00
Immuneering (IMRX) United States $0.063B 0.00
FibroBiologics (FBLG) United States $0.062B 0.00
Kronos Bio (KRON) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.059B 0.00
Connect Biopharma Holdings (CNTB) United States $0.058B 0.00
Boundless Bio (BOLD) United States $0.056B 0.00
Immix Biopharma (IMMX) United States $0.056B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
IO Biotech (IOBT) Denmark $0.055B 0.00
Repare Therapeutics (RPTX) Canada $0.054B 0.00
Inovio Pharmaceuticals (INO) United States $0.054B 0.00
PDS Biotechnology (PDSB) United States $0.054B 0.00
Earth Science Tech (ETST) United States $0.054B 0.00
Shattuck Labs (STTK) United States $0.053B 0.00
Ovid Therapeutics (OVID) United States $0.053B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.052B 0.00
Fortress Biotech (FBIO) United States $0.052B 0.00
Celularity (CELU) United States $0.051B 0.00
Xilio Therapeutics (XLO) United States $0.050B 0.00
Spero Therapeutics (SPRO) United States $0.050B 13.00
Invivyd (IVVD) United States $0.049B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.047B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.046B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.045B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Aileron Therapeutics (RNTX) United States $0.043B 0.00
Estrella Immunopharma (ESLA) United States $0.043B 0.00
Elevation Oncology (ELEV) United States $0.042B 0.00
Rapt Therapeutics (RAPT) United States $0.042B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.042B 0.00
Intensity Therapeutics (INTS) United States $0.042B 0.00
CalciMedica (CALC) United States $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.041B 0.00
Clene (CLNN) United States $0.040B 0.00
Q32 Bio (QTTB) United States $0.040B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Precision BioSciences (DTIL) United States $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.038B 0.00
Atara Biotherapeutics (ATRA) United States $0.038B 0.00
Grace Therapeutics (GRCE) Canada $0.037B 0.00
Passage Bio (PASG) United States $0.037B 0.00
Rallybio (RLYB) United States $0.036B 0.00
RenovoRx (RNXT) United States $0.036B 0.00
Opus Genetics (IRD) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
MiNK Therapeutics (INKT) United States $0.035B 0.00
Enzo Biochem (ENZ) United States $0.034B 0.00
KALA BIO (KALA) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
SAB Biotherapeutics (SABS) United States $0.033B 0.00
Medicus Pharma (MDCX) Canada $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.031B 0.00
Lisata Therapeutics (LSTA) United States $0.031B 0.00
Cadrenal Therapeutics (CVKD) United States $0.031B 0.00
Chemomab Therapeutics (CMMB) Israel $0.031B 0.00
Omega Therapeutics (OMGA) United States $0.030B 0.00
Beyond Air (XAIR) United States $0.030B 0.00
UNITY Biotechnology (UBX) United States $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Cognition Therapeutics (CGTX) United States $0.028B 0.00
Curis (CRIS) United States $0.028B 0.00
Exicure (XCUR) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
LakeShore Biopharma (LSB) China $0.025B 0.00
Longeveron (LGVN) United States $0.025B 0.00
Prana Biotechnology (ATHE) Australia $0.025B 0.00
Pluri (PLUR) Israel $0.024B 0.00
BioAtla (BCAB) United States $0.024B 0.00
HOOKIPA Pharma (HOOK) United States $0.024B 0.00
Cyclo Therapeutics (CYTH) United States $0.023B 0.00
Equillium (EQ) United States $0.023B 0.00
Forte Biosciences (FBRX) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.022B 0.00
NextCure (NXTC) United States $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.022B 0.00
IN8bio (INAB) United States $0.021B 0.00
Senti Biosciences (SNTI) United States $0.021B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.021B 0.00
Cara Therapeutics (CARA) United States $0.021B 0.00
GeoVax Labs (GOVX) United States $0.021B 0.00
Aprea Therapeutics (APRE) United States $0.021B 0.00
Gelteq (GELS) Australia $0.021B 0.00
Athira Pharma (ATHA) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Bolt Biotherapeutics (BOLT) United States $0.020B 0.00
OnKure Therapeutics (OKUR) United States $0.019B 0.00
Ocean Biomedical (OCEA) United States $0.019B 0.00
Affimed (AFMD) Germany $0.019B 0.00
Palvella Therapeutics (PVLA) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
BioXcel Therapeutics (BTAI) United States $0.017B 0.00
MetaVia (MTVA) United States $0.017B 0.00
BRIACELL THERAP (BCTX) Canada $0.017B 0.00
NKGen Biotech (NKGN) United States $0.016B 0.00
Cingulate (CING) United States $0.015B 0.00
Spruce Biosciences (SPRB) United States $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
CervoMed (CRVO) United States $0.013B 0.00
Aptose Biosciences (APTO) Canada $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Carmell (CTCX) United States $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
BioAffinity Technologies (BIAF) United States $0.011B 0.00
Apollomics (APLM) United States $0.010B 0.00
Hoth Therapeutics (HOTH) United States $0.010B 0.00
Turnstone Biologics (TSBX) United States $0.010B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Mainz Biomed (MYNZ) Germany $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
Silo Pharma (SILO) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Eyenovia (EYEN) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Moleculin Biotech (MBRX) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.005B 0.00
Vincerx Pharma (VINC) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Evaxion Biotech (EVAX) Denmark $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NAYA Biosciences (NAYA) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00